Jefferies Starts Orchestra BioMed Inc. (OBIO) at Buy, 'Partnership-Enabled Model with Two Exciting Lead Programs'

January 19, 2024 1:00 AM EST Send to a Friend
(Updated - January 19, 2024 4:20 AM EST)

Jefferies analyst Matthew Taylor initiates coverage on Orchestra BioMed Inc. (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login